To include your compound in the COVID-19 Resource Center, submit it here.

ToleroMune cat allergy therapy: Additional Phase II data

Data from a 12-month follow-up of a double-blind, placebo-controlled, Canadian Phase II trial in 202 patients with confirmed cat allergies showed

Read the full 216 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE